• Title/Summary/Keyword: Pharmacotherapy

Search Result 215, Processing Time 0.026 seconds

Developing Method of Auxiliary Label by Korean Braillewritier Letter for Drug Consultation (한국인 시각 장애우 환자의 복약지도 증진을 위한 점자용 보조라벨 개발의 필요성과 개발방법 제시)

  • Lim, Sung-Cil;Lee, Myung-Koo;Lee, Chong-Kil;Lee, Bo-Reum
    • YAKHAK HOEJI
    • /
    • v.52 no.3
    • /
    • pp.201-211
    • /
    • 2008
  • All pharmacists must provide the drug consultation whenever dispense drugs to patients by the Korean Pharmacy Law. Drug consultation is very important procedure for increasing pharmacotherapy. Because it maximizes the therapeutic effects or/and minimizes adverse drug reaction during the drug therapy. However, it is not easy to do because of the dynamic and hectic pharmacy environment. Especially, if someone has a disabling body function, they required more time and efforts to perform consultation by pharmacist. Currently several auxiliary labels for helping drug consultation are using in pharmacy practice but not for disabling patients. Therefore we developed the total 53 auxiliary labels with size of 0.7 cm (width) and 1 cm (length) by Braillewriter letters for blind patients. This research has been performed for total 12 months (Mar. 15ts, 2007$\sim$Feb. 25th, 2008) and the developing methods are consisted of 4 steps: 1) selection of essential informations, 2) simplification of information, 3) changing for Braillewriter letters, 4) application and revising by blindness patients. Also the labels are consisted of 12 for adverse reactions and precautions, 8 for directions, 2 for storages, 9 for duration, 9 for dosage forms, and 12 for common names. After developed those labels, we revised those labels by discussion with 2 blind people. In conclusion, the new auxiliary labels for blind patients can increase therapeutic effects and decrease risks from pharmacotherapy besides decreasing of pharmacist's work load in the future.

A Systematic Review and Meta-Analysis of Randomized Controlled Trials on Chuna Manual Therapy for Cervicogenic Headache

  • Lee, Dong-Wha;Kim, Ju-Young;Hong, Min-Ho;Koo, Byung-Soo;Kim, Geun-Woo
    • Journal of Oriental Neuropsychiatry
    • /
    • v.30 no.2
    • /
    • pp.89-105
    • /
    • 2019
  • Objectives: We conducted this study to evaluate the efficacy of Chuna Manual Therapy (CMT) for treatment of cervicogenic headache (CeH) through systematic review and Meta-analysis of randomized controlled trials (RCTs) as a preceding research to further research the effective of Chuna Manual Therapy for patients who suffered from CeH. Methods: We conducted a systematic review and meta-analysis by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched the studies from MEDLINE, Elsevier-EMBASE, The Cochrane Library, CAJD, KISS, KMBase, Korean Traditional Knowledge Portal, NDSL, and OASIS. The studies selected only in randomized controlled trials. We selected the chosen studies by the selection and the exclusion criteria, and evaluated the quality of the selected studies using the Jadad score and the Cochran ROB tool. We used the Visual Analogue Scale score (VAS) and Clinical total Effective Rate (CER) for the results and analyzed the results of the included studies using RevMan 5.3 software provided by the Cochran library. Results: We included 20 RCTs, including 1,673 subjects, in the systematic review and meta-analysis. After the intervention, the CMT group showed better results than the pharmacotherapy group, the physiotherapy group, and the combined treatment group. The CMT group showed a good effect on the CER and the VAS but showed a significant heterogeneity compared to the pharmacotherapy group. Conclusions: The CMT as monotherapy might have benefits on Cervicogenic Headache patient. Further well-designed studies need to be conducted.

Comparison of Attention-Deficit/Hyperactivity Disorder Practice in Adults According to a Training Background in Child Psychiatry

  • Hong, Minha;Lee, Seung-Yup;Lee, Young Sik;Kim, Bongseog;Joung, Yoo Sook;Yoo, Hanik K;Kim, Eui-Jung;Lee, Soyoung Irene;Park, Su-Bin;Bhang, Soo-Young;Han, Doughyun;Bahn, Geon Ho
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • v.30 no.3
    • /
    • pp.121-126
    • /
    • 2019
  • Objectives: Awareness of attention-deficit/hyperactivity disorder (ADHD) in adults has significantly increased; however, clinical data specific to the Korean population are insufficient. Clinical experience of ADHD may differ based on whether psychiatrists have received pediatric psychiatry-specific training. In order to prepare a practice parameter for adult ADHD patients in Korea, we examined questionnaire data to observe how pediatric psychiatry training could affect clinical practice for adults with ADHD. Methods: A questionnaire about the diagnosis and treatment process was distributed to both general psychiatrists (GPsy) and child and adolescent psychiatrists (CAP) at the summer and winter workshop meetings of Korean Academy of Child and Adolescent Psychiatry. Results: In total, 142 psychiatrists participated in the survey (86 GPsy, 56 CAP). GPsy and CAP preferred pharmacotherapy (GPsy 82.40%, CAP 64.30%) as the primary treatment option and answered that the clinical psychiatric interview is the most necessary step in diagnostic assessment (GPsy 22.16%, CAP 19.00%). The GPsy responded with an optimal and average treatment duration that was shorter than that reported by CAP. Conclusion: Identification of the initial presenting symptom as the correct diagnosis and the optimal duration of pharmacotherapy differed between GPsy and CAP in practice, whereas concepts in diagnosis and treatment of ADHD in adults were similar for both groups. These results suggest the urgent need for the Continuing Medical Education program for psychiatrists treating adults with ADHD.

A CASE REPORT OF TRIGEMINAL NEURALGIA TREATED BY ALCOHOL INJECTION AND PHARMACOTHERAPY (삼차신경통의 효과적인 치료법과 증례)

  • Kim, Kwang-Hyun;Kim, Hong-Ki;Kim, Moon-Gon
    • The Journal of the Korean dental association
    • /
    • v.10 no.4
    • /
    • pp.233-236
    • /
    • 1972
  • The authors have effectively treated a case of true trigeminal neuralgia involving the 3rd branch of the 5th cranial nerve by mandibular nerve block with alcohol and Dilantin administration, and reached following results. 1. Alcohol injection has a definite value as the primary treatment of trigeminal neuralgia. 2. It is not yet to be clarified whether the effects of alcohol injection and Dilantin therapy reveal synergism. 3. Phenobarital was given as an adjuvant of Dilantin, but its effect on the painful paroxysms is questionable.

  • PDF

Molecular Docking Study of Urotension-2 Receptor (UTS2R)

  • Sathya., B
    • Journal of Integrative Natural Science
    • /
    • v.10 no.2
    • /
    • pp.105-109
    • /
    • 2017
  • Urotensin-2 receptor (UTS2R) is the most potent vasoconstrictor and plays a major role in the pathophysiology of various cardiovascular diseases and becomes a potential target for human pharmacotherapy. Hence, we have performed molecular docking of six antagonists with different inhibitory activity against UTS2R into its binding site. The binding mode of these antagonists was obtained using Surflex dock program interfaced in Sybyl-X2.0. The residues such as GLN278, THR304, TYR305, THR300, LEU299, CYS302, ASP47, TYR100 and THR304 are found in interaction between UTS2R and its antagonists. This study could be useful for identifying and analyzing the important residues involved in binding site of UTS2R receptor.

Development of a Pharmaceutical Care Service Model for Patients with Diabetes in Ambulatory Care Settings (외래환자 대상 당뇨병 약료서비스 모델 개발)

  • Yoon, Jeong-Hyun
    • Korean Journal of Clinical Pharmacy
    • /
    • v.27 no.1
    • /
    • pp.1-8
    • /
    • 2017
  • The prevalence of diabetes and its related morbidity and mortality are being increased. Despite the advancement of evidence-based pharmacotherapy in the management of diabetes, many patients in our country do not achieve satisfied therapeutic outcomes. Pharmaceutical care service can be defined as a patient-centered clinical service provided by pharmacists to improve therapeutic outcomes and quality of life of patients, by identifying, and preventing or resolving drug-related problems (DRPs). Pharmaceutical care service is interdisciplinary team-based practice, and is provided through collaborative practice agreement (CPA) between one or more physicians and pharmacists. This article describes a model of pharmaceutical care service which can be adopted in our country for patients with diabetes in the ambulatory care settings. With the successful implementation of this service, clinical, economic, and humanistic outcomes of patients will be improved. Therefore, by actively implementing pharmaceutical care service, pharmacist should contribute to the promotion of patients' health and to the advancement of health care delivery system.

Smoking Cessation (금연)

  • Kim, Yong-Hyun;Lee, Sang-Haak
    • Tuberculosis and Respiratory Diseases
    • /
    • v.69 no.3
    • /
    • pp.153-162
    • /
    • 2010
  • Smoking is the most important risk factor of many pulmonary diseases, including chronic obstructive pulmonary disease and lung cancer, cardiovascular disorders and other malignancies. Therefore, smoking cessation is a practical way to prevent and treat smoking-related diseases. Also, the clinicians who care the patients with smoking-related disease should pay attention to it. This article reviews briefly recent publications focused on the influence of smoking cessation in some smoking-related diseases and strategies to improve smoking cessation such as pharmacotherapy or systemic behavioral approach programs. In addition, it reviews personalized therapy based on gene typing for smoking cessation.

Globus Pallidus Interna Deep Brain Stimulation for Chorea-Acanthocytosis

  • Lee, Jae-Hyeok;Cho, Won-Ho;Cha, Seung-Heon;Kang, Dong-Wan
    • Journal of Korean Neurosurgical Society
    • /
    • v.57 no.2
    • /
    • pp.143-146
    • /
    • 2015
  • Chorea-acanthocytosis (ChAc) is a rare hereditary disorder characterized by involuntary choreiform movements and erythrocytic acanthocytosis. Pharmacotherapy for control of involuntary movements has generally been of limited benefit. Deep brain stimulation (DBS) has recently been used for treatment of some refractory cases of ChAc. We report here on the effect of bilateral high-frequency DBS of globus pallidus interna in a patient with ChAc.

Off-label use of Psychotropic Medications in Preschool Children with Attention-deficit Hyperactivity Disorder (주의력결핍 과잉행동장애에서 허가 초과 약물 처방 : 학령전기 아동 중심으로)

  • Kim, Eui-Jung
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • v.22 no.2
    • /
    • pp.74-80
    • /
    • 2011
  • Attention-deficit hyperactivity disorder (ADHD) is a neurobehavioral disorder with an onset of symptoms before 7 years of age, often starting as early as the preschool years. The off-label use of methylphenidate (MPH) for 3- to 6-year-old preschool children with ADHD is being more common, although MPH is not licensed for use in children younger than age 6 years, in most countries. Despite the limited data, the review of the literature suggests that MPH meets evidence based criteria as beneficial and safe for carefully diagnosed ADHD preschool children. Carefully monitored administration of evidence-based psychotropic medication in preschool children with ADHD may be indicated if psychosocial treatments are ineffective.

Novel Pharmacological Treatment for Depression (새로운 우울증 치료 약물)

  • Jeong, Hee Jeong;Moon, Eunsoo
    • Korean Journal of Biological Psychiatry
    • /
    • v.23 no.1
    • /
    • pp.1-11
    • /
    • 2016
  • Development of various antidepressants such as monoamine oxidase inhibitors, tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and noradrenergic and specific serotonergic antidepressant has led to a tremendous progression of pharmaceutical treatment for depression, but still there are some limitations of current antidepressants, such as treatment-resistant depression and delayed onset of antidepressants. The pathogenesis of depression is unclear because depression is a heterogeneous disease state, and the mechanisms of antidepressants remain uncertain as well. Nevertheless, in an attempt to develop novel antidepressants, some trials have been conducted based on the potential biological mechanism discovered in the numerous research results. This review will provide information about the potential novel antidepressants and the current states of clinical studies using them. In particular, some potential novel antidepressants anti-inflammatory agents, antioxidants, anticholinergics, modulators of Hypothalamic Pituitary Adrenal Axis, glutamate, and opioid systems, as well as some neuropeptides such as susbstance P, neuropeptide Y, and galanin will be discussed.